Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-22-004363
Filing Date
2022-09-27
Accepted
2022-09-27 16:30:27
Documents
1
Period of Report
2022-09-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5125
  Complete submission text file 0000902664-22-004363.txt   7104
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Reporting) CIK: 0001493215 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39971 | Film No.: 221271467

Mailing Address C/O RTW INVESTMENTS, LP 40 10TH AVENUE, 7TH FLOOR NEW YORK NY 10014
Business Address
WONG RODERICK (Reporting) CIK: 0001493280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39971 | Film No.: 221271466

Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

EIN.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations